Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Buntanetap

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annovis Releases Alzheimer's Phase 2/3 Trial Results In Nature
    Annovis Releases Alzheimer's Phase 2/3 Trial Results In Nature

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282572/0/en/annovis-publishes-phase-2-3-alzheimer-s-trial-results-in-nature-portfolio.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Annovis Raises $10M for Ph 3 Alzheimer Disease's NDA Submission
    Annovis Raises $10M for Ph 3 Alzheimer Disease's NDA Submission

    10 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/10/3271713/0/en/Annovis-Closes-10-Million-Offering-Extending-Cash-Runway-Through-Phase-3-Alzheimer-s-Disease-6-Month-NDA-Submission.html

    GLOBENEWSWIRE
    10 Apr 2026
    Share Share
    Annovis Launches $10M Common Stock Offering With Warrants
    Annovis Launches $10M Common Stock Offering With Warrants

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270958/0/en/Annovis-Announces-10-Million-Underwritten-Offering-of-Common-Stock-and-Accompanying-Warrants.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Annovis Patents Buntanetap for Neurological Infection Injuries
    Annovis Patents Buntanetap for Neurological Infection Injuries

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267248/0/en/Annovis-Secures-U-S-Patent-for-Buntanetap-in-the-Prevention-and-Treatment-of-Neurological-Injuries-Caused-by-Brain-Infections.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Annovis Publishes Historical Review in The Scientist
    Annovis Publishes Historical Review in The Scientist

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265424/0/en/Annovis-Publishes-Historical-Review-of-Buntanetap-in-The-Scientist.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Annovis Reports Fiscal Year 2025 Financial Results
    Annovis Reports Fiscal Year 2025 Financial Results

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256164/0/en/Annovis-Provides-Corporate-Updates-and-Reports-Fiscal-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.